ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2012

Oct 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2012-10-18

Reporting Person: Clendeninn Neil James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-18	Common Stock	M	513	$4.1051	Acquired	7562	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-18	Stock Option	$4.1051	M	513	Disposed	2013-03-23	Common Stock (513)	Direct